Trials / Completed
CompletedNCT03452644
US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors
Diagnostic Yield of Ultrasound-Guided Needle Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (actual)
- Sponsor
- Istituto Ortopedico Rizzoli · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A retrospective evaluation of soft tissue tumors that have undergone core needle biopsy with US guidance (US-CNB)
Detailed description
The present study is designed to be the first step in the creation of an interdisciplinary platform collecting data on patients and procedures to provide a predictive tool to help physicians in the management of patients affected by a soft tissue lesion. The primary aim of our work is to evaluate the diagnostic yield of US-CNB. The secondary aim is to exploit all the imaging data conventionally available at a Sarcoma Center before a biopsy on a soft tissue mass, to build a multiparametric model and score of prediction of malignancy, and eventually of biological behavior - grading.
Conditions
Timeline
- Start date
- 2018-09-20
- Primary completion
- 2019-01-15
- Completion
- 2020-09-20
- First posted
- 2018-03-02
- Last updated
- 2023-05-23
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT03452644. Inclusion in this directory is not an endorsement.